首页> 外文期刊>International Journal of Cancer =: Journal International du Cancer >Loss of stromal JUNB does not affect tumor growth and angiogenesis
【24h】

Loss of stromal JUNB does not affect tumor growth and angiogenesis

机译:基质JUNB的丢失不影响肿瘤生长和血管生成

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The transcription factor AP-1 subunit JUNB has been shown to play a pivotal role in angiogenesis. It positively controls angiogenesis by regulating Vegfa as well as the transcriptional regulator Cbfb and its target Mmp13. In line with these findings, it has been demonstrated that tumor cell-derived JUNB promotes tumor growth and angiogenesis. In contrast to JUNB's function in tumor cells, the role of host-derived stromal JUNB has not been elucidated so far. Here, we show that ablation of Junb in stromal cells including endothelial cells (ECs), vascular smooth muscle cells (SMCs) and fibroblasts does not affect tumor growth in two different syngeneic mouse models, the B16-F1 melanoma and the Lewis lung carcinoma model. In-depth analyses of the tumors revealed that tumor angiogenesis remains unaffected as assessed by measurements of the microvascular density and relative blood volume in the tumor. Furthermore, we could show that the maturation status of the tumor vasculature, analyzed by the SMC marker expression, α-smooth muscle actin and Desmin, as well as the attachment of pericytes to the endothelium, is not changed upon ablation of Junb. Taken together, these results indicate that the pro-angiogenic functions of stromal JUNB are well compensated with regard to tumor angiogenesis and tumor growth. What's new? JUNB is a subunit of the AP-1 transcription factor and a critical activator of Vegfa, the master regulator of angiogenesis. Here, the authors used conditional Junb knockout mice to define the role of stromal JUNB on tumor growth and angiogenesis. Surprisingly, although tumor-derived JUNB is known to critically regulate these properties, stromal, host-derived JUNB is dispensable for these processes. The study indicates that loss of stromal JUNB is well compensated by the tumor itself as well as infiltrating immune cells that provide pro-angiogenic factors and matrix metalloproteinases otherwise induced by JUNB expression in the tumor microenvironment.
机译:转录因子AP-1亚基JUNB已显示在血管生成中起关键作用。它通过调节Vegfa以及转录调节因子Cbfb及其靶Mmp13来积极地控制血管生成。与这些发现一致,已经证明源自肿瘤细胞的JUNB促进肿瘤生长和血管生成。与JUNB在肿瘤细胞中的功能相反,宿主来源的基质JUNB的作用迄今尚未阐明。在这里,我们显示在包括内皮细胞(ECs),血管平滑肌细胞(SMCs)和成纤维细胞在内的基质细胞中,Junb的消融不会影响两种不同的同系小鼠模型B16-F1黑色素瘤和Lewis肺癌模型中的肿瘤生长。对肿瘤的深入分析显示,通过测量肿瘤中的微血管密度和相对血容量可以评估,肿瘤血管生成仍不受影响。此外,我们可以显示,通过SMC标记表达,α-平滑肌肌动蛋白和Desmin以及周细胞对内皮的附着,分析肿瘤血管的成熟状态在Junb消融后不会改变。综上所述,这些结果表明基质JUNB的促血管生成功能在肿瘤血管生成和肿瘤生长方面得到了很好的补偿。什么是新的? JUNB是AP-1转录因子的亚基,是血管生成的主要调节剂Vegfa的关键激活剂。在这里,作者使用条件性Junb基因敲除小鼠来定义基质JUNB在肿瘤生长和血管生成中的作用。出人意料的是,尽管已知肿瘤来源的JUNB可以严格调节这些特性,但基质,宿主来源的JUNB对于这些过程却是必不可少的。研究表明,基质JUNB的丧失可以被肿瘤本身以及浸润的免疫细胞很好地补偿,这些免疫细胞可以提供原血管生成因子和基质金属蛋白酶,否则它们会在肿瘤微环境中被JUNB表达诱导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号